The benefits of risk assessment tools for prostate cancer
Eur Urol
.
2012 Apr;61(4):662-3.
doi: 10.1016/j.eururo.2011.12.012.
Epub 2011 Dec 20.
Authors
Ian M Thompson
,
Donna P Ankerst
PMID:
22197470
PMCID:
PMC5034859
DOI:
10.1016/j.eururo.2011.12.012
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Male
Mass Screening*
Prostatic Neoplasms / diagnosis*
Grants and funding
P30 CA054174/CA/NCI NIH HHS/United States
U01 CA086402/CA/NCI NIH HHS/United States